For Immediate Release
Chicago, IL – May 17, 2012 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include NYSE Euronext Inc. (), CME Group Inc. (CME - Free Report) , IntercontinentalExchange Inc. (ICE - Free Report) , JP Morgan Chase & Co. (JPM - Free Report) and Goldman Sachs Group Inc. (GS - Free Report) .
Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: https://at.zacks.com/?id=5513
Here are highlights from Wednesday’s Analyst Blog:
NYSE Pushed Off LME Bid
The Financial Times reported that the US derivative exchange giant – NYSE Euronext Inc. has been pushed out of the London Metal Exchange (LME) buyout battle owing to its low bid price.
However, other potential buyers – Hong Kong Stock Exchange, CME Group Inc. (CME - Free Report) and IntercontinentalExchange Inc. ((ICE - Free Report) ) – are still running neck-to-neck in the race. While NYSE’s bid was valued at £800 million ($1.28 billion), the other three bidders have reportedly made biddings worth over £1.0 billion
Founded in 1877, LME is the world's largest futures exchange, which offers futures and options contracts on base and other metals, which include aluminium, aluminium alloy, NASAAC (North American Special Aluminium Alloy), cobalt, copper, lead, molybdenum, nickel, steel billet, tin and zinc.
LME is owned by 93 members, the top-most shareholders being JP Morgan Chase & Co. (JPM - Free Report) and Goldman Sachs Group Inc. (GS - Free Report) with 10.9% and 9.5% stakes. LME is also one of the last member-owned exchanges in the world wherein trading is conducted through the open-outcry system in the ring by the ring dealing members. In addition to the 12 companies who have exclusive rights to trade in the ring, around 100 companies are involved in the LME in total.
As the LME offers contracts with daily expiry dates of up to three months from the trade date, along with longer-dated contracts up to 123 months, it also allows for cash trading. Furthermore, it offers hedging, worldwide reference pricing and the option of physical delivery to settle contracts.
Accordingly, the preliminary bid for LME started in September last year and was closed in February this year. While LME is mulling over the right price and future of the deal, the actual bid offers of the three remaining contestants remain undisclosed.
Scope of Growth for Derivative Giants
After the collapse of its merger deal with Deutsche Boerse, NYSE had shown significant interest in LME as this metal exchange’s business blends well with NYSE Liffe’s soft and agricultural commodity derivative business. NYSE Liffe is the former London International Financial Futures Exchange, which trades coffee, sugar, cocoa and wheat futures. While LME and NYSE Liffe already share the same storehouses for delivery of commodities, the combined trades could be cleared at NYSE Liffe Clear, which is currently at a nascent stage of growth. Hence, this effort could have paved way for a new earnings opportunity, had the deal materialized.
On the other hand, addition of LME to CME’s basket could enhance its metals exchange, Comex. Hence, the deal is also considered important for other derivative exchanges, such as CME and IntercontinentalExchange, in order to boost their competitive strength in Europe.
Besides, Hong Kong stock exchange is desperately looking forward to the culmination of this deal so that it can tap the volatile European markets to drive growth momentum in the markets of China.
While the owners of LME are apprehensive about safeguarding its business model, we believe the complex structure of its futures contracts and its network of registered warehouses could pose some issues in the business sale. Nevertheless, given the gravity of the changing business dynamics in this industry and the lucrative pricing of the bids, a final outcome is expected soon.
Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: https://at.zacks.com/?id=5515.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: https://at.zacks.com/?id=5517
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leon Zacks. As a PhD from MIT Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at https://at.zacks.com/?id=5518.
Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Zacks Investment Research
800-767-3771 ext. 9339